AI heart scan screening for cardiomyopathy
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study uses artificial intelligence (AI) to look at heart CT scans (coronary CT angiograms) to help spot different types of cardiomyopathy (diseases of the heart muscle) earlier and more accurately. If you have a cardiomyopathy and have had a heart CT scan before any surgery or device placement, this study may help improve diagnosis and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of a type of cardiomyopathy (a heart muscle disease) — or, for the control group, no known heart disease at all.
- You need to have had at least one coronary CT angiogram (a special CT scan of the heart's blood vessels) before any heart surgery or implantable device placement.
- Any heart surgery or implantable device must have been done after your CT scan, not before.
- Your cardiomyopathy diagnosis should be clear and not caused by another disease in the body.
- If you are in the control group, you must not have any history of heart attack, heart surgery, stent, or implantable defibrillator.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to help diagnose and predict outcomes for people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes thickened. It may help doctors better understand your condition and plan your care.
This study uses artificial intelligence to analyze heart tests (ECGs) to help diagnose and predict outcomes for people with heart disease. It may lead to better and faster detection of heart conditions.
This trial is testing a new artificial intelligence system that helps doctors take clearer, faster heart images using MRI. It aims to make heart scans more accurate and comfortable for patients.
This study uses artificial intelligence (AI) to look at your heart tests (ECG and echo) and find people who might have a specific heart muscle disease called ATTR-CM. The goal is to catch it earlier so treatment can start sooner.
This study uses artificial intelligence to analyze your heart CT scan and better predict your risk of coronary artery disease (narrowing of the arteries that supply your heart). The goal is to help doctors identify who might need earlier treatment or more careful monitoring.
This study at Mayo Clinic is testing an artificial intelligence (AI) tool that analyzes echocardiograms (ultrasound of the heart) to find early signs of four types of heart muscle disease. If the AI flags a high-risk pattern, doctors can learn whether acting on that alert helps catch the condition sooner.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.